Lilly, Novartis Help Forma Therapeutics Raise $25 Million To Expand R&D In Asia

SHANGHAI - Forma Therapeutics has closed a new financing venture round, which amounted to $25.5 million and was led by investors from Lilly Ventures, Novartis Option Fund and Bio*One Capital of Singapore